Perna-Barrull, David http://orcid.org/0000-0003-2079-818X
Gomez-Muñoz, Laia http://orcid.org/0000-0001-9640-6213
Rodriguez-Fernandez, Silvia http://orcid.org/0000-0001-8429-4293
Gieras, Anna http://orcid.org/0000-0002-5147-2281
Ampudia-Carrasco, Rosa M. http://orcid.org/0000-0002-0734-0433
Almenara-Fuentes, Lidia http://orcid.org/0000-0002-8518-8078
Risueño, Ruth M. http://orcid.org/0000-0003-4048-9536
Querol, Sergi http://orcid.org/0000-0002-1105-8633
Tolosa, Eva http://orcid.org/0000-0002-5247-8378
Vives-Pi, Marta http://orcid.org/0000-0003-3735-0779
Funding for this research was provided by:
deutsche forschungsgemeinschaft (KFO296)
Departament de Salut, Generalitat de Catalunya (SLT017/20/000049, DI2021-69)
Universitat Autònoma de Barcelona
Article History
Received: 28 July 2022
Accepted: 28 October 2022
First Online: 18 December 2022
Declarations
:
: MVP is co-founder and SEO of Ahead Therapeutics SL. LAF and SRF are employees of this company. The remaining authors declare no competing financial and/or non-financial interests concerning the work described.
: This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Generalitat de Catalunya, Catalan Government. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Germans Trias i Pujol Research Institute (Permit DAAM 8948). Cord blood samples were obtained from anonymous donors via the “Banc de sang i teixits” (BST) research biobank and the procedure was approved by the Germans Trias i Pujol Hospital Ethical Committee (PI-19-128). All subjects gave written informed consent forms at the BST in accordance with the Declaration of Helsinki and the study was carried out after the approval and in strict accordance with the guidelines of Germans Trias i Pujol Research Institute and Hospital Ethical Committee.
: We confirm that the manuscript follows the recommendations in the Arrive guidelines.